Considering that both of these two SCCs bear a significant burden of p53 loss-of-function mutations [2,55,56], this underscored the need to investigate mechanisms that operate independently of p53 activation in the context of HPV-negative HNSCC and CSCC. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.